past-patient-access-awards-winners-trophy past-patient-access-awards-winners-trophy

Patient Access
Award Winners

Winners across therapeutic areas are recognized by payers and physicians for their dedication for smoothing patient access.

Q2 2022 Winners

Oncology

Novartis (Acute Lymphoblastic Leukemia)

Pfizer, Inc. (Acute Myeloid Leukemia)

Bristol-Myers Squibb (Chronic Myeloid Leukemia)

Bristol-Myers Squibb (Non-Hodgkin's Lymphoma)

Biologics & Injectables

Novo Nordisk (Diabetes)

Pfizer, Inc. (Atopic Dermatitis)

Janssen Pharmaceuticals (Psoriasis)

Amgen (Psoriatic Arthritis)

Sanofi (Severe Asthma)

Q1 2022 Winners

Oncology

Novartis (Breast Cancer)

Merck & Co. (Metastatic Melanoma)

Bristol-Myers Squibb (Non-Small Cell Lung Cancer)

Bristol-Myers Squibb (Bladder Cancer)

Biologics & Injectables

CSL Behring (Hereditary Angioedema)

Pfizer, Inc. (Growth Hormone Deficiency)

Janssen Pharmaceuticals (Growth Hormone Deficiency)

Novartis (Multiple Sclerosis)